Technology

CHIME Unveils Comprehensive AI Principles to Guide Healthcare Transformation

Published

2 years ago

July 31, 2024

ANN ARBOR, Mich., July 31, 2024 /PRNewswire/ — The College of Healthcare Information Management Executives (CHIME) has unveiled a comprehensive set of ten AI principles designed to ensure ethical and effective implementation of artificial intelligence (AI) in healthcare. These principles aim to enhance patient care, support healthcare providers, and foster innovation while maintaining robust safeguards and trust among patients and providers.

CHIME has unveiled 10 AI principles designed to ensure ethical and effective implementation of AI in healthcare.

CHIME represents the voice of over 5,000 senior-level digital health leaders worldwide, who understand the critical importance of these principles for the healthcare industry. Developed in conjunction with our Policy Steering Committee and based on feedback from our CHIME members, these principles reflect the collective expertise and insights of those on the front lines of healthcare. As AI accelerates changes in the healthcare system, CHIME members are at the forefront, navigating this dynamic landscape. This positions CHIME to lend its voice and thought leadership, supporting policymakers in charting a responsible path forward that supports care delivery while fostering innovation.

“AI has the potential to revolutionize patient care and healthcare operations, but it must be implemented thoughtfully to ensure it enhances, rather than compromises, patient safety,” said Russ P. Branzell, CHCIO, LCHIME, President and CEO of CHIME. “Our principles provide a roadmap for achieving this balance, supporting both innovation and rigorous oversight.”

The AI principles cover a range of critical areas, including patient safety, administrative efficiencies, regulatory oversight, innovation, bias and equity, affordability, privacy, cybersecurity, high-speed broadband, and education and workforce development. They reflect months of input from CHIME members, who are on the front lines of navigating this dynamic landscape.

Patient Safety: Ensuring AI enhances patient care without compromising safety.Administrative Efficiencies: Leveraging AI to reduce costs and improve efficiency.Regulatory Oversight: Implementing balanced regulation that protects patients without adding undue burden for providers.Innovation & Research: Promoting continuous innovation and high standards for use in patient care and improving operational efficiencies.Discrimination, Bias & Equity: Monitoring AI to prevent discriminatory outcomes and enhance fairness.Affordability: Ensuring AI accessibility to all healthcare providers, preventing a digital divide.Privacy: Maintaining robust patient data privacy and security.Cybersecurity: Investing in cybersecurity to help providers improve their cybersecurity posture and better protect healthcare data.High-Speed Broadband: Expanding broadband access to harness AI tools and reduce disparities in healthcare.Education & Workforce: Supporting education and workforce development to manage new AI tools and labor demands.

“As the current Chair of the CHIME Board of Trustees, I believe that our AI principles are pivotal for the healthcare sector,” said Scott MacLean, CHCIO, FCHIME, LCHIME, Senior Vice President and Chief Information Officer at MedStar Health. “These principles provide a framework that ensures patient safety, enhances administrative efficiencies, and strengthens cybersecurity, all while fostering innovation and addressing critical issues like discrimination and equity in healthcare. By utilizing them, we can improve healthcare through the safe, responsible use of AI tools – ultimately leading to better outcomes for providers and patients alike. CHIME members embrace AI as a force for good. By considering and using our AI principles, we can enhance patient care, empower clinicians, and contribute to healthier communities.”

The principles also include specific recommendations for policymakers to support the responsible development and deployment of AI in healthcare. These recommendations emphasize the need for collaboration among providers, clinicians, technology companies, educators, policymakers, and other stakeholders.

For more information and to download the full set of AI principles, visit: https://chimedhl.org/3ymkdua.

About CHIME
The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs) and other senior healthcare IT leaders. With more than 5,000 individual members in 58 countries and two U.S. territories and over 180 CHIME Foundation healthcare IT business and professional service firm members, CHIME and its three associations provide a highly interactive, trusted environment enabling senior professional and industry leaders to collaborate, exchange best practices, address professional development needs and advocate for the effective use of information management to improve the health and care in the communities they serve. For more information, please visit chimecentral.org.

For media inquiries, please contact:

Contact
Calli Dretke
Executive Vice President & Chief Digital and Marketing Officer
CHIME
734.412.6255
cdretke@dhinsights.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/chime-unveils-comprehensive-ai-principles-to-guide-healthcare-transformation-302210436.html

SOURCE College of Healthcare Information Management Executives (CHIME)

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

55 minutes ago

October 23, 2026

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

2 hours ago

October 22, 2026

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

2 hours ago

October 22, 2026

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.